New obesity drug may be harmful for children: Study
Saturday, May 10th, 2008An anti-obesity drug which suppresses appetite blocks the cannabinoid receptors in the brain, which can even suppress the adaptive rewiring of the brain and is necessary for neural development in children, show studies conducted on mice. Rimonabant (trade name Acomplia) is a drug which has been created by Sanofi-Aventis who is yet waiting for […]